切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - c-Fms tyrosine kinase - CRM1 - Leukotriene and Related Receptors

10 件产品

每页
清除全部
  1. MK-571
    B7023 MK-571
    Target: Leukotriene and Related Receptors
    Summary: leukotriene D4(LTD4)受体拮抗剂
      ≥55.1 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. KPT-276
    B1463 KPT-276
    Target: nuclear export|CRM1
    Summary: CRM1抑制剂
      ≥19.85 mg/mL
      insoluble in H2O
  5. Zafirlukast
    B2068 Zafirlukast
    中文名: 扎鲁司特
    Target: Leukotriene and Related Receptors
    Summary: 口服白三烯受体拮抗剂
      ≥23.9 mg/mL
      insoluble in H2O
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms酪氨酸激酶抑制剂
      ≥48.1 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页